The findings of a recent research study have caused quite a bit of a stir in my social media streams. The study suggests that gender stereotypes surface at the age of 6. As a consequence, girls seem to think boys are the smart gender. The worry is that this leads to less girls and women choosing STEM (science – tech – engineering […]
Daclizumab, marketed as Zinbryta, was approved for the treatment of relapsing-remitting multiple sclerosis (MS) in the USA and Europe in summer 2016. Daclizumab has shown superior efficacy when compared to placebo and a standard treatment (AVONEX®, interferon beta-1a) and is believed to be on a par with other novel treatments. It is a once-monthly subcutaneous injection which the patient can administer themselves. This is quite convenient to […]
Elahe is originally from Iran, and I always find it fascinating to talk to her. Why? Because I can learn about an unfamiliar world. I don’t know an awful lot about Iran; just bits I snap up through the media. I can ask Elahe naïve questions without fear of judgement or ridicule. She dispels my misconceptions and widens my viewpoint. […]
It is a specialist skill to write in a manner that is accepted and credible in the academic realm. To complicate matters, different scientific journals have varying styles and expectations. The acceptance of a paper for publication does not only hinge on the brilliance of the scientific work, but also on the manner in which it is conveyed – the […]
After I tweeted about my recent post about Immunium, another Twitter user made me aware of iCancer. Why? – Because the clinical trial financed through the iCancer fundraising campaign used the Ad5PTDf35-adenovirus vector which Immunicum includes as one of their treatment platforms under development.
I thought I kick off the year with an article about Immunicum, a Swedish company I stumbled across a week or so ago. As an immunologist by training I have a soft spot for companies looking to exploit the versatility and strength of our own immune system. Immunicum does just that. In their own words, they aim to create “the […]